Tandem Diabetes Care: Q4 Earnings Insights

Tandem Diabetes Care TNDM reported its Q4 earnings results on Tuesday, February 22, 2022 at 04:05 PM.

Here's what investors need to know about the announcement.

Tandem Diabetes Care missed estimated earnings by 23.81%, reporting an EPS of $0.16 versus an estimate of $0.21.

Revenue was up $41.93 million from the same period last year.

Last quarter the company beat on EPS by $0.03 which was followed by a 6.29% drop in the share price the next day.

Here's a look at Tandem Diabetes Care's past performance:

Quarter	Q3 2021	Q2 2021	Q1 2021	Q4 2020
EPS Estimate	0.06	-0.08	-0.16	0.12
EPS Actual	0.09	0.06	-0.08	0.22
Revenue Estimate	171.41M	143.63M	121.96M	141.58M
Revenue Actual	179.63M	172.14M	141.04M	168.06M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar